303 related articles for article (PubMed ID: 28513059)
1. Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies.
Gao SY; Wu QJ; Zhang TN; Shen ZQ; Liu CX; Xu X; Ji C; Zhao YH
Br J Clin Pharmacol; 2017 Oct; 83(10):2134-2147. PubMed ID: 28513059
[TBL] [Abstract][Full Text] [Related]
2. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies.
Addis A; Koren G
Psychol Med; 2000 Jan; 30(1):89-94. PubMed ID: 10722179
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence.
Grigoriadis S; VonderPorten EH; Mamisashvili L; Roerecke M; Rehm J; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE
J Clin Psychiatry; 2013 Apr; 74(4):e293-308. PubMed ID: 23656855
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
6. Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies.
Zhang TN; Gao SY; Shen ZQ; Li D; Liu CX; Lv HC; Zhang Y; Gong TT; Xu X; Ji C; Wu QJ
Sci Rep; 2017 Feb; 7():43085. PubMed ID: 28220881
[TBL] [Abstract][Full Text] [Related]
7. The fetal safety of fluoxetine: a systematic review and meta-analysis.
Riggin L; Frankel Z; Moretti M; Pupco A; Koren G
J Obstet Gynaecol Can; 2013 Apr; 35(4):362-369. PubMed ID: 23660045
[TBL] [Abstract][Full Text] [Related]
8. Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies.
Shen ZQ; Gao SY; Li SX; Zhang TN; Liu CX; Lv HC; Zhang Y; Gong TT; Xu X; Ji C; Wu QJ; Li D
Br J Clin Pharmacol; 2017 Apr; 83(4):909-922. PubMed ID: 27770542
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
[TBL] [Abstract][Full Text] [Related]
10. Effects of third trimester fluoxetine exposure on the newborn.
Goldstein DJ
J Clin Psychopharmacol; 1995 Dec; 15(6):417-20. PubMed ID: 8748430
[TBL] [Abstract][Full Text] [Related]
11. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.
Einarson TR; Einarson A
Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):823-7. PubMed ID: 15742359
[TBL] [Abstract][Full Text] [Related]
12. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study.
Bateman BT; Hernandez-Diaz S; Straub L; Zhu Y; Gray KJ; Desai RJ; Mogun H; Gautam N; Huybrechts KF
BMJ; 2021 Feb; 372():n102. PubMed ID: 33568363
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT
JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849
[TBL] [Abstract][Full Text] [Related]
14. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
[TBL] [Abstract][Full Text] [Related]
15. First-trimester exposure to bupropion and risk of cardiac malformations.
Louik C; Kerr S; Mitchell AA
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1066-75. PubMed ID: 24920293
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
Malm H
Ther Drug Monit; 2012 Dec; 34(6):607-14. PubMed ID: 23042258
[TBL] [Abstract][Full Text] [Related]
18. Sertraline use during pregnancy and the risk of major malformations.
Bérard A; Zhao JP; Sheehy O
Am J Obstet Gynecol; 2015 Jun; 212(6):795.e1-795.e12. PubMed ID: 25637841
[TBL] [Abstract][Full Text] [Related]
19. Birth outcomes in pregnant women taking fluoxetine.
Johnson GL
J Fam Pract; 1997 Jan; 44(1):32. PubMed ID: 9010368
[No Abstract] [Full Text] [Related]
20. Effects of first-trimester fluoxetine exposure on the newborn.
Goldstein DJ; Corbin LA; Sundell KL
Obstet Gynecol; 1997 May; 89(5 Pt 1):713-8. PubMed ID: 9166307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
